FFCP PHASE1:Hg19::chrX:123480179..123480190,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=4068 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=10820 | |||
|TSSclassifier=strong | |||
|UniProt=O60880 | |||
|association_with_transcript=-3bp_to_ENST00000371139_5end | |||
|cluster_id=chrX:123480179..123480190,+ | |||
|coexpression_cluster_id=C386 | |||
|description=CAGE_peak_9_at_SH2D1A_5end | |||
|id=chrX:123480179..123480190,+ | |||
|ontology_enrichment_celltype=CL:0000084!4.03e-12!25;CL:0000827!4.03e-12!25;CL:0000080!3.33e-10!6;CL:0000838!8.20e-09!52;CL:0000542!1.28e-08!53;CL:0000051!1.28e-08!53;CL:0000988!6.66e-08!182;CL:0002127!1.75e-07!1;CL:0000914!1.75e-07!1;CL:0000911!1.75e-07!1;CL:0000814!1.75e-07!1;CL:0002042!1.75e-07!1;CL:0002039!1.75e-07!1;CL:0002040!1.75e-07!1;CL:0002041!1.75e-07!1 | |||
|ontology_enrichment_celltype_v019=CL:0000084;1.16e-12;25 | |||
|ontology_enrichment_celltype_v019_2=CL:0000084,1.18e-12,25;CL:0000827,1.18e-12,25;CL:0000838,1.03e-10,52;CL:0000542,1.61e-10,53;CL:0000051,1.61e-10,53 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:2531!1.40e-13!51;DOID:0060083!1.40e-13!51;DOID:1240!1.33e-09!39;DOID:4960!3.80e-08!1;DOID:0070004!3.80e-08!1;DOID:0060060!4.07e-08!1;DOID:0060061!4.07e-08!1;DOID:8691!4.07e-08!1 | |||
|ontology_enrichment_disease_v019=DOID:4960;8.34e-34;1!DOID:0070004;8.34e-34;1!DOID:2531;1.12e-08;51!DOID:0060083;1.12e-08;51 | |||
|ontology_enrichment_disease_v019_2=DOID:4960,9.85e-34,1;DOID:0070004,9.85e-34,1;DOID:2531,6.05e-11,51;DOID:0060083,6.05e-11,51;DOID:1240,2.08e-08,39 | |||
|ontology_enrichment_uberon=UBERON:0000178!1.13e-20!15;UBERON:0000179!1.13e-20!15;UBERON:0000463!1.13e-20!15;UBERON:0002370!5.33e-15!4;UBERON:0005058!5.33e-15!4;UBERON:0009113!5.33e-15!4;UBERON:0003295!5.33e-15!4;UBERON:0005562!5.33e-15!4;UBERON:0004177!9.09e-15!7;UBERON:0003351!3.55e-10!6;UBERON:0002390!3.76e-08!102;UBERON:0003061!3.76e-08!102;UBERON:0001282!1.64e-07!1;UBERON:0009842!1.64e-07!1;UBERON:0003704!1.64e-07!1;UBERON:0001171!1.64e-07!1;UBERON:0001172!1.64e-07!1;UBERON:0002193!3.24e-07!112 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.32389366601898,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.128091319725675,0.520237390239513,0,0.276350017785848,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24930726552346,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.441463099414651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.112085143993527,0.197030760201927,0,0,0,0,0,0,0,0,0,0.414415513436035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.764637207142375,0.569647187174163,0,0.822724546172388,0,0,0,0,0,0,0,0,0.782560276832555,2.23196781820351,0,2.8725805519855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.556812347790485,0,0,0,0,0,0,0,0.111443384277478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.3948309234694,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.113942055847001,0,0,0,0,0,0,9.19739683761629,0,0,0,0.19606253431774,0,0,0,0,0,0,0,0,0,0,0.296521128680622,0.123563938946503,0.730953646538188,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.999936979274649,0,1.03328987796489,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.128915775947154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.581300188524055,0.31037357147929,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201273793591026,0 | |||
|short_description=p9@SH2D1A | |||
}} |
Latest revision as of 08:01, 19 September 2015
Short description: | p9@SH2D1A |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_9_at_SH2D1A_5end |
Coexpression cluster: | C386_chronic_acute_Hodgkin_NK_thymus_liver_blood |
Association with transcript: | -3bp_to_ENST00000371139_5end |
EntrezGene: | SH2D1A |
HGNC: | 10820 |
UniProt: | O60880 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
T cell | 1.18e-12 | 25 |
pro-T cell | 1.18e-12 | 25 |
lymphoid lineage restricted progenitor cell | 1.03e-10 | 52 |
lymphocyte | 1.61e-10 | 53 |
common lymphoid progenitor | 1.61e-10 | 53 |
Ontology term | p-value | n |
---|---|---|
bone marrow cancer | 9.85e-34 | 1 |
myeloma | 9.85e-34 | 1 |
hematologic cancer | 6.05e-11 | 51 |
immune system cancer | 6.05e-11 | 51 |
leukemia | 2.08e-08 | 39 |